210 related articles for article (PubMed ID: 1939385)
1. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
[TBL] [Abstract][Full Text] [Related]
2. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
[TBL] [Abstract][Full Text] [Related]
3. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
Cumming P; Léger GC; Kuwabara H; Gjedde A
J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
[TBL] [Abstract][Full Text] [Related]
5. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
Kuwabara H; Cumming P; Reith J; Léger G; Diksic M; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1993 Jan; 13(1):43-56. PubMed ID: 8417009
[TBL] [Abstract][Full Text] [Related]
6. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Kumakura Y; Vernaleken I; Gründer G; Bartenstein P; Gjedde A; Cumming P
J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
[TBL] [Abstract][Full Text] [Related]
7. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
Reith J; Dyve S; Kuwabara H; Guttman M; Diksic M; Gjedde A
J Cereb Blood Flow Metab; 1990 Sep; 10(5):707-19. PubMed ID: 2117017
[TBL] [Abstract][Full Text] [Related]
9. Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics.
Stout DB; Huang SC; Melega WP; Raleigh MJ; Phelps ME; Barrio JR
J Cereb Blood Flow Metab; 1998 Jan; 18(1):43-51. PubMed ID: 9428304
[TBL] [Abstract][Full Text] [Related]
10. Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint on the distribution of volume of 30MFD: a PET investigation using non-human primates.
Shoghi-Jadid K; Huang SC; Stout DB; Yee RE; Yeh EL; Farahani KF; Satyamurthy N; Phelps ME; Barrio JR
J Cereb Blood Flow Metab; 2000 Jul; 20(7):1134-48. PubMed ID: 10908046
[TBL] [Abstract][Full Text] [Related]
11. The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.
Wahl L; Chirakal R; Firnau G; Garnett ES; Nahmias C
J Cereb Blood Flow Metab; 1994 Jul; 14(4):664-70. PubMed ID: 8014214
[TBL] [Abstract][Full Text] [Related]
12. Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
Endres CJ; DeJesus OT; Uno H; Doudet DJ; Nickles JR; Holden JE
Front Biosci; 2004 Jan; 9():505-12. PubMed ID: 14766386
[TBL] [Abstract][Full Text] [Related]
13. The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
Brust P; Vorwieger G; Walter B; Füchtner F; Stark H; Kuwabara H; Herzau M; Opfermann T; Steinbach J; Ganapathy V; Bauer R
Brain Res Dev Brain Res; 2004 Sep; 152(2):241-53. PubMed ID: 15351512
[TBL] [Abstract][Full Text] [Related]
14. Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
Wahl L; Nahmias C
J Nucl Med; 1996 Mar; 37(3):432-7. PubMed ID: 8772639
[TBL] [Abstract][Full Text] [Related]
15. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
[TBL] [Abstract][Full Text] [Related]
16. Developmental changes in the activities of aromatic amino acid decarboxylase and catechol-O-methyl transferase in the porcine brain: a positron emission tomography study.
Brust P; Walter B; Hinz R; Füchtner F; Müller M; Steinbach J; Bauer R
Neurosci Lett; 2004 Jul; 364(3):159-63. PubMed ID: 15196667
[TBL] [Abstract][Full Text] [Related]
17. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.
Deep P; Gjedde A; Cumming P
J Neurosci Methods; 1997 Oct; 76(2):157-65. PubMed ID: 9350967
[TBL] [Abstract][Full Text] [Related]
18. Plasma L-[18F]6-fluorodopa input function: a simplified method.
Chan GL; Morrison KS; Holden JE; Ruth TJ
J Cereb Blood Flow Metab; 1992 Sep; 12(5):881-4. PubMed ID: 1506454
[TBL] [Abstract][Full Text] [Related]
19. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
20. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
Firnau G; Sood S; Chirakal R; Nahmias C; Garnett ES
J Nucl Med; 1988 Mar; 29(3):363-9. PubMed ID: 3126278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
